Immunologic targets in psoriasis
- PMID: 14627782
- DOI: 10.1056/NEJMp038164
Immunologic targets in psoriasis
Comment in
-
Etanercept for Crohn's disease.N Engl J Med. 2004 Feb 19;350(8):840; author reply 840. doi: 10.1056/NEJM200402193500818. N Engl J Med. 2004. PMID: 14973205 No abstract available.
Comment on
-
A novel targeted T-cell modulator, efalizumab, for plaque psoriasis.N Engl J Med. 2003 Nov 20;349(21):2004-13. doi: 10.1056/NEJMoa030002. N Engl J Med. 2003. PMID: 14627785 Clinical Trial.
-
Etanercept as monotherapy in patients with psoriasis.N Engl J Med. 2003 Nov 20;349(21):2014-22. doi: 10.1056/NEJMoa030409. N Engl J Med. 2003. PMID: 14627786 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical